Shanghai Pharma to Form $470 Million China Healthcare VC Fund

Shanghai Pharmaceuticals, China's largest drug distributor, will launch a China healthcare venture capital investment fund that will ultimately raise $470 million. The first tranche will be $157 million and Shanghai Pharma will contribute 25% of that, or just under $40 million. The VC fund will back healthcare start-ups in all life science fields. The news came from a securities filing. More details.... Stock Symbol: (SHA: 600196) Share this with colleagues: // //